Long-term survival after treatment for primary anal cancer– results from the Swedish national ANCA cohort study

References

• Islami F, Ferlay J, Lortet-Tieulent J, et al. International trends in anal cancer incidence rates. Int J Epidemiol. 2017;46(3):924–938.
   PubMed Web of Science ®Google Scholar
• Guren MG, Aagnes B, Nygard M, et al. Rising incidence and improved survival of anal squamous cell carcinoma in Norway, 1987–2016. Clin Colorectal Cancer. 2019;18(1):e96–e103.
   PubMed Web of Science ®Google Scholar
• Deshmukh AA, Suk R, Shiels MS, et al. Incidence trends and burden of human Papillomavirus-associated cancers among women in the United States, 2001–2017. J Natl Cancer Inst. 2021;113(6):792–796.
   PubMedGoogle Scholar
• Kang YJ, Smith M, Canfell K. Anal cancer in high-income countries: increasing burden of disease. PLoS One. 2018;13(10):e0205105.
   PubMed Web of Science ®Google Scholar
• Bjorge T, Engeland A, Luostarinen T, et al. Human papillomavirus infection as a risk factor for anal and perianal skin cancer in a prospective study. Br J Cancer. 2002; 87(1):61–64.
   PubMed Web of Science ®Google Scholar
• Glynne-Jones R, Nilsson PJ, Aschele C, et al. Anal cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up. Eur J Surg Oncol. 2014; 40(10):1165–1176.
   PubMed Web of Science ®Google Scholar
• Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR anal cancer trial working party. UK Co-ordinating committee on cancer research. Lancet. 1996;348(9034):1049–1054.
   PubMed Web of Science ®Google Scholar
• Werner RN, Gaskins M, Avila Valle G, et al. State of the art treatment for stage I to III anal squamous cell carcinoma: a systematic review and meta-analysis. Radiother Oncol. 2021;157:188–196.
   PubMed Web of Science ®Google Scholar
• Leon O, Guren M, Hagberg O, et al. Anal carcinoma - survival and recurrence in a large cohort of patients treated according to Nordic guidelines. Radiother Oncol. 2014;113(3):352–358.
   PubMed Web of Science ®Google Scholar
• Slørdahl KS, Klotz D, Olsen J, et al. Treatment outcomes and prognostic factors after chemoradiotherapy for anal cancer. Acta Oncol. 2021;60(7):921–930.
   PubMed Web of Science ®Google Scholar
• Hagemans JAW, Blinde SE, Nuyttens JJ, et al. Salvage abdominoperineal resection for squamous cell anal cancer: a 30-year single-institution experience. Ann Surg Oncol. 2018;25(7):1970–1979.
   PubMed Web of Science ®Google Scholar
• Nilsson PJ, Svensson C, Goldman S, et al. Salvage abdominoperineal resection in anal epidermoid cancer. Br J Surg. 2002;89(11):1425–1429.
   PubMed Web of Science ®Google Scholar
• Bentzen AG, Guren MG, Wanderas EH, et al. Chemoradiotherapy of anal carcinoma: survival and recurrence in an unselected national cohort. Int J Radiat Oncol Biol Phys. 2012; Jun 183(2):e173–e180.
   PubMed Web of Science ®Google Scholar
• Bosset JF, Pavy JJ, Roelofsen F, et al. Combined radiotherapy and chemotherapy for anal cancer. EORTC radiotherapy and gastrointestinal cooperative groups. Lancet. 1997;349(9046):205–206.
   PubMed Web of Science ®Google Scholar
• Bartelink H, Roelofsen F, Eschwege F, et al. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European organization for research and treatment of cancer radiotherapy and gastrointestinal cooperative groups. J Clin Oncol. 1997;15(5):2040–2049.
   PubMed Web of Science ®Google Scholar
• Gunderson LL, Winter KA, Ajani JA, et al. Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil/mitomycin versus fluorouracil/cisplatin. J Clin Oncol. 2012;30(35):4344–4351.
   PubMed Web of Science ®Google Scholar
• James RD, Glynne-Jones R, Meadows HM, et al. Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2 × 2 factorial trial. The Lancet Oncology. 2013;14(6):516–524.
   PubMed Web of Science ®Google Scholar
• Ricci-Cabello I, Vasquez-Mejia A, Canelo-Aybar C, et al. Adherence to breast cancer guidelines is associated with better survival outcomes: a systematic review and meta-analysis of observational studies in EU countries. BMC Health Serv Res. 2020;20(1):920.
   PubMed Web of Science ®Google Scholar